newsfilter
← Latest News
Business Wire·

New Analyses of the MIRROR Randomized Controlled Trial in Uncontrolled Gout Presented at the 2023 EULAR European Congress of Rheumatology

-- New data illustrate impact of KRYSTEXXA® (pegloticase) injection with methotrexate to improve patient outcomes and clinical measures for uncontrolled gout -- Horizon Therapeutics plc (NASDAQ:HZNP) today